Palo Alto, Calif.-based Theranos has hired two new executives to oversee all regulatory, quality and compliance standards, according to Reuters.
The blood testing company named Daniel Guggenheim, JD, as chief compliance officer. Formerly, he served as an assistant general counsel at San Francisco-based McKesson.
Dave Wurtz, who previously served as an executive at Waltham, Mass.-based Thermo Fisher Scientific, was appointed vice president of regulatory and quality.
Theranos said its board of directors also created a compliance and quality committee.
Theranos came under fire last October when the Food and Drug Administration issued a lab inspection reports claiming the company had used an unapproved medical device and lacked proper quality control procedures, both of which jeopardized patient health and safety.
More articles on leadership:
11 hospitals with great customer service
CS Mott Children's Hospital embraces Pokémon GO to raise kids' energy
15 healthcare companies on Fortune's Global 500 list